1. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
- Author
-
Sergio D. Rosenzweig, Karen P. Lau, Cathleen Frein, Gulbu Uzel, Alexandra F. Freeman, E. Liana Falcone, Beatriz E. Marciano, Lisa A. Barnhart, Debra A. Long Priel, Danielle Fink, Victoria L. Anderson, John I. Gallin, Ladan Foruraghi, Harry L. Malech, Douglas B. Kuhns, Lynne Yockey, Suk See DeRavin, Sally Hunsberger, Samantha Kreuzburg, Kabir Matharu, Janine Daub, Li Ding, Christa S. Zerbe, Dirk Darnell, and Steven M. Holland
- Subjects
0301 basic medicine ,Adult ,Infection risk ,Heterozygote ,Dihydrorhodamine 123 ,Adolescent ,Immunology ,Biology ,medicine.disease_cause ,Granulomatous Disease, Chronic ,Infections ,Autoimmunity ,03 medical and health sciences ,Young Adult ,Chronic granulomatous disease ,Genes, X-Linked ,X Chromosome Inactivation ,medicine ,Odds Ratio ,Immunology and Allergy ,Humans ,CYBB ,Child ,Genetic Association Studies ,Aged ,Aged, 80 and over ,Carrier state ,Infant ,Odds ratio ,Middle Aged ,medicine.disease ,030104 developmental biology ,Phenotype ,Immunoglobulin M ,Child, Preschool ,Immunoglobulin G ,Mutation ,Female ,Symptom Assessment ,Identical twins ,Biomarkers - Abstract
Background Chronic granulomatous disease (CGD) is characterized by recurrent life-threatening bacterial and fungal infections and aberrant inflammation. Mutations in CYBB cause X-linked CGD and account for 65% to 70% of cases in Western countries. Objective We sought to understand the clinical manifestations associated with the X-linked CGD carrier state. Methods We undertook a comprehensive retrospective study of 162 affected female subjects. We examined dihydrorhodamine 123 (DHR) oxidation data for percentage of X-chromosome inactivation. We correlated lyonization (%DHR + ) with clinical features. Where possible, we followed %DHR + values over time. Results Clinical data were available for 93 female subjects: %DHR + values were 46% (mean) and 47% (median; SD, 24). Using the %DHR + value as the criterion for X inactivation, 78% of patients had levels of inactivation of 20% to 80%, suggesting random inactivation that was independent of age. In contrast, carriers with CGD-type infections had median %DHR + values of 8% (n = 14; range, 0.06% to 48%), and those with only autoimmune or inflammatory manifestations had median %DHR + values of 39% (n = 31; range, 7.4% to 74%). Those with both infections and autoimmunity had low %DHR + values (n = 6; range, 3% to 14%). A %DHR + value of less than 10% was strongly associated with infections (odds ratio, 99). Strong association persisted when %DHR + values were less than 20% (odds ratio, 12). Autoimmunity was not associated with %DHR + values. In 2 sets of identical twins, the %DHR + populations tracked closely over time. Although the %DHR + populations were very similar between sisters, those between mothers and daughters were unrelated. Conclusions A low %DHR + value strongly predicts infection risk in X-linked CGD carriers, and the carrier state itself is associated with autoimmunity.
- Published
- 2016